Peregrine Pharmaceuticals Investigational Site — Boston, Massachusetts

Peregrine Pharmaceuticals Investigational Site is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Peregrine Pharmaceuticals Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Non-Small-Cell Lung Cancer Stage IIIB, Non-Small-Cell Lung Cancer Stage IV, Non-Small-Cell Lung Cancer Metastatic.

Sponsors: Peregrine Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Peregrine Pharmaceuticals Investigational Site?

Peregrine Pharmaceuticals Investigational Site has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Peregrine Pharmaceuticals Investigational Site conducted?

Peregrine Pharmaceuticals Investigational Site has 1 clinical trials on record. Their work covers Non-Small-Cell Lung Cancer Stage IIIB, Non-Small-Cell Lung Cancer Stage IV, Non-Small-Cell Lung Cancer Metastatic.

Is Peregrine Pharmaceuticals Investigational Site accredited by Crixeo Health?

Peregrine Pharmaceuticals Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Peregrine Pharmaceuticals Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.